QA: Biofrontera Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001858685_2026_Biofrontera_Inc.pdf

Logs

Graph

Absolute values for 0001858685, Biofrontera Inc

  xvar xval
0 AssetsCurrent 18,083,000
1 IntangibleAssetsNetIncludingGoodwill 2,650,000
2 PropertyPlantAndEquipmentNet 2,158,000
3 remainder_Assets 5,673,000
4 LiabilitiesCurrent 11,895,000
5 LiabilitiesNoncurrent 1,249,000
6 remainder_Liabilities 4,940,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 22,878,573
9 ResearchAndDevelopmentExpense 8,811,646
10 remainder_Expenses 41,027,538
11 remainder_Revenues 43,242,760
12 remainder_NetIncome 280,397
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 28,564,000
1 Liabilities 18,084,000
2 Expenses 72,717,757
3 Revenues 43,242,760
4 StockholdersEquity 10,480,000
5 NetIncome -29,194,600
6 ComprehensiveNetIncome -29,194,600
7 BaseVar 81,444,457
8 EconomicCapitalRatiobeforeLimitedLiability -0.272
9 EconomicCapitalRatio 1.40

Edgar->Model Mapping

Feature Distribution

Change over Time